Paul Reider

Paul Reider joined Coherus in 2021 and is currently Chief Commercial Officer. Paul brings 30 years of biotechnology industry sales and marketing experience across oncology, rheumatology, endocrinology and rare disease therapeutic areas.

Prior to Coherus, he served as Vice President of Sales and Strategic Accounts for Puma Biotechnology. Prior to Puma, he worked at Ipsen Biopharmaceuticals where he led the establishment of a new U.S.-based oncology commercial team and subsequently served as the General Manager of Ipsen Canada. Prior to Ipsen, Mr. Reider founded Raven Management, LLC, a consulting practice focused on commercial projects for biopharmaceutical clients in Oncology and other specialty therapeutic areas. From 1996 to 2013, Mr. Reider held marketing and executive leadership roles over 17 years at Amgen including Marketing lead for the U.S. launch of Neulasta®, Brand Director of the Filgrastim Franchise, Executive Director of Corporate Accounts, commercial leader for the establishment of Amgen affiliates in Mexico and Brazil and founding member of the Bone Health Business Unit overseeing the U.S. launch of Prolia®.

Mr. Reider earned a B.S. in Business Administration and a M.B.A. from Bowling Green State University.